OncoGenex is a biopharmaceutical company uniquely focused on cancer treatment resistance. It is committed to the development and commercialization of first-in-class, innovative therapies that target mechanisms of resistance and that have the potential to re-define treatment paradigms in a variety of cancers.
Investment year: 2002
Industry sector: Medical/health
Region: Prairies and West